AF

Avanza Fonder Portfolio holdings

AUM $3.86B
1-Year Est. Return 26.15%
This Quarter Est. Return
1 Year Est. Return
+26.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.38B
AUM Growth
+$328M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
492
New
Increased
Reduced
Closed

Top Buys

1 +$18.4M
2 +$17.1M
3 +$16.6M
4
INTU icon
Intuit
INTU
+$14.9M
5
GEV icon
GE Vernova
GEV
+$13.7M

Top Sells

1 +$14.4M
2 +$11.4M
3 +$9.83M
4
NVDA icon
NVIDIA
NVDA
+$8.89M
5
AMT icon
American Tower
AMT
+$6.77M

Sector Composition

1 Technology 37.73%
2 Consumer Discretionary 14.58%
3 Financials 12.02%
4 Communication Services 10.72%
5 Healthcare 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBP icon
426
Corbus Pharmaceuticals
CRBP
$166M
$49.3K ﹤0.01%
7,150
WSC icon
427
WillScot Mobile Mini Holdings
WSC
$3.62B
$39.3K ﹤0.01%
1,434
-2,654
TREX icon
428
Trex
TREX
$3.74B
$35.3K ﹤0.01%
650
SHIM icon
429
Shimmick
SHIM
$93.1M
$34.2K ﹤0.01%
20,000
GTES icon
430
Gates Industrial
GTES
$5.63B
$30.3K ﹤0.01%
1,317
-6,196
GPK icon
431
Graphic Packaging
GPK
$4.54B
$28.5K ﹤0.01%
1,351
-2,314
QRHC icon
432
Quest Resource Holding
QRHC
$43M
$16.7K ﹤0.01%
8,287
-12,297
TROW icon
433
T. Rowe Price
TROW
$22.6B
$11.2K ﹤0.01%
116
-17,691
AVTR icon
434
Avantor
AVTR
$7.69B
-62,760
PRME icon
435
Prime Medicine
PRME
$729M
-23,918
PSTG icon
436
Pure Storage
PSTG
$23B
-6,704
ACHR icon
437
Archer Aviation
ACHR
$5.75B
-66,941
AMT icon
438
American Tower
AMT
$84.4B
-31,079
APTV icon
439
Aptiv
APTV
$16.7B
-22,696
BAX icon
440
Baxter International
BAX
$10B
-41,552
BEAM icon
441
Beam Therapeutics
BEAM
$2.72B
-51,077
BEN icon
442
Franklin Resources
BEN
$12.3B
-17,000
BEPC icon
443
Brookfield Renewable
BEPC
$6.93B
-10,380
BMRN icon
444
BioMarin Pharmaceuticals
BMRN
$10B
-20,915
BXP icon
445
Boston Properties
BXP
$11.3B
-12,298
CABA icon
446
Cabaletta Bio
CABA
$230M
-17,605
CERS icon
447
Cerus
CERS
$386M
-110,315
CF icon
448
CF Industries
CF
$12.3B
-16,484
COIN icon
449
Coinbase
COIN
$67.5B
-16,664
CRSP icon
450
CRISPR Therapeutics
CRSP
$5.36B
-25,341